sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
vyndaqel
pfizer europe ma eeig - tafamidis - amyloidose - andre narkotika stoffer - vyndaqel er indiceret til behandling af transthyretinamyloidose hos voksne patienter med fase 1-symptomatisk polyneuropati for at forsinke perifer neurologisk nedsat funktion.
ziprasidon "pfizer" 10 mg/ml oral suspension
pfizer aps - ziprasidonhydrochlorid - oral suspension - 10 mg/ml
calciumfolinat "pfizer" 10 mg/ml injektionsvæske, opløsning
pfizer aps - calciumfolinat - injektionsvæske, opløsning - 10 mg/ml
celecoxib "pfizer" 200 mg kapsler, hårde
pfizer aps - celecoxib - kapsler, hårde - 200 mg
eletriptanhydrobromid "pfizer" 20 mg filmovertrukne tabletter
pfizer aps - eletriptanhydrobromid - filmovertrukne tabletter - 20 mg
eletriptanhydrobromid "pfizer" 40 mg filmovertrukne tabletter
pfizer aps - eletriptanhydrobromid - filmovertrukne tabletter - 40 mg
eplerenon "pfizer" 25 mg filmovertrukne tabletter
pfizer aps - eplerenon - filmovertrukne tabletter - 25 mg
eplerenon "pfizer" 50 mg filmovertrukne tabletter
pfizer aps - eplerenon - filmovertrukne tabletter - 50 mg
meropenem "pfizer" 500 mg pulver til injektions-/infusionsvæske, opløsning
pfizer aps - meropenem (trihydrat) - pulver til injektions-/infusionsvæske, opløsning - 500 mg